Patent: 6,187,319
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 6,187,319
Title: | Cross-protective rotavirus vaccine |
Abstract: | A method of producing an effective immune response in an animal against a first rotavirus, by (1) identifying an animal susceptible to or having a first rotavirus infection; and (2) administering to the animal an isolated VP6 polypeptide of a second rotavirus sufficient to produce an effective immune response against the first rotavirus, the second rotavirus capable of infecting a different species than the first rotavirus. |
Inventor(s): | Herrmann; John E. (Northborough, MA), Lu; Shan (Northborough, MA) |
Assignee: | University of Massachusetts (Boston, MA) |
Application Number: | 09/088,216 |
Patent Claims: | see list of patent claims |
Details for Patent 6,187,319
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2039-02-26 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2039-02-26 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2039-02-26 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |